2月6日创新医疗（002173）收盘报27.56元，跌6.1%，当日成交5614.46万元。前10个交易日资金流向情 况：主力资金累计净流出3.71亿元，股价累计下跌7.76%；融资余额累计减少2343.86万元，融券余量累 计增加2000股。 截至2026年2月6日收盘，创新医疗(002173)报收于27.56元，下跌6.1%，换手率13.49%，成交量56.14万 手，成交额15.58亿元。 当日关注点 交易信息汇总 来自交易信息汇总：2月6日创新医疗（002173）收盘报27.56元，跌6.1%，主力资金当日净流出 1.39亿元。 来自交易信息汇总：前10个交易日主力资金累计净流出3.71亿元，股价累计下跌7.76%。 2月6日主力资金净流出1.39亿元；游资资金净流入469.64万元；散户资金净流入1.34亿元。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 ...

行 业 297 机械设备 2026 年 02 月 08 日 研 究 中央政治局集体学习聚焦脑机接口等未来产业技术，解 码脑机接口产业发展内核 投资要点： 认清产业本质，脑机接口是超复杂系统工程 行 业 定 期 报 告 中央政治局第二十四次集体学习将脑机接口列为未来产业重点方 向，在脑机接口明确为未来产业重点方向之后，一个更值得深入讨论 的问题是：脑机接口究竟是一类什么样的产业形态——其并非单一技 术领域，而是兼具技术高度耦合、产业链与跨学科跨度大的超复杂系 统工程，由神经科学研究、硬件制造、算法研发等多子系统构成，各 环节动态闭环且相互制约。我国当前发展该产业存在明显短板，核心 软硬件存在外部依赖形成的 "软硬分离" 问题，同时脑数据标准不 统一、算力调度分散等基础设施薄弱问题，也制约了技术迭代与产业 发展。 聚焦系统构建，多维度夯实产业发展底座 我国脑机接口产业已进入底座构建期，发展的关键并非单点技术 突破，而是完成系统整合的跃迁。需先明确国家级技术路线图并建设 脑数据国家库等共享基础设施，再建立科研、产业、区域多层级协同 机制，同时完善覆盖全生命周期的监管体系并参与国际标准制定，更 要通过高校交叉学科布局 ...

证券之星消息，截至2026年2月5日收盘，创新医疗(002173)报收于29.35元，上涨0.82%，换手率 17.39%，成交量72.38万手，成交额21.02亿元。 2月5日的资金流向数据方面，主力资金净流出5376.28万元，占总成交额2.56%，游资资金净流入 2663.53万元，占总成交额1.27%，散户资金净流入2712.74万元，占总成交额1.29%。 近5日资金流向一览见下表： 该股主要指标及行业内排名如下： 创新医疗2025年三季报显示，前三季度公司主营收入5.97亿元，同比下降2.11%；归母净利润472.44万 元，同比上升116.97%；扣非净利润-2946.98万元，同比上升6.05%；其中2025年第三季度，公司单季度 主营收入1.96亿元，同比下降3.16%；单季度归母净利润1608.57万元，同比上升236.15%；单季度扣非 净利润-1658.58万元，同比下降12.36%；负债率17.84%，投资收益2950.55万元，财务费用60.55万元， 毛利率10.08%。创新医疗（002173）主营业务：提供医疗服务。 资金流向名词解释：指通过价格变化反推资金流向。股价处于上升状 ...

每经AI快讯，2月5日，A股脑机接口板块尾盘回升，爱朋医疗短线拉升涨超4%，创新医疗、博拓生 物、可孚医疗、塞力医疗等个股跟涨。消息面上，中国提出多项APEC合作项目，涉及脑机接口技术 等。 每日经济新闻 ...

Core Insights - The article highlights the significant growth in the approval of innovative medical devices in China, indicating a strong focus on innovation and regulatory support in the sector [1] Group 1: Approval Statistics - In 2025, a total of 76 innovative medical devices were approved for market entry, representing a year-on-year increase of 17%, with a cumulative total of 391 devices approved [1] - There were 25 medical devices that received priority approval for market entry, showing a remarkable year-on-year growth of 212.5%, leading to a cumulative total of 171 devices approved [1]

Core Insights - The report highlights the strong performance of the domestic financial market, with the Shanghai Composite Index closing at 4102.2, up by 0.85% [4] - It emphasizes the ongoing sector rotation, with funds shifting from high-tech stocks to consumer and new energy sectors due to increasing uncertainties as the Spring Festival approaches [10] Macroeconomic News Summary - The Central Committee and State Council issued opinions on advancing rural revitalization [6] - The central bank aims to support key areas such as expanding domestic demand and technological innovation in the 2026 credit market [6] - The Ministry of Industry and Information Technology is focused on advancing key technologies in AI and manufacturing [6] Industry Updates - NAND flash memory prices are expected to rise over 40% quarter-on-quarter in Q1 2026, with related stocks including Zhaoyi Innovation and Northern Huachuang [7] - The first "Traditional Chinese Medicine Brain-Computer Interface" has been established, with related stocks including Sanbo Brain Science and Innovative Medical [7] - In January, 36 Chinese companies made it to the global top 100 mobile game publishers by revenue, with related stocks including Century Huatong and Kaiying Network [7] Company Focus - Rongda Photoelectric plans to complete its first high-end photoresist production line by the second half of 2026 [8] - Huagong Technology is focused on manufacturing engines and precision components, with ongoing customer certifications for its communication modules [8] - Xingye Silver Tin's Vice President increased his shareholding, reflecting confidence in the company's long-term value [8] - Qianli Technology's subsidiary has achieved L3-level intelligent driving capabilities and has applied for testing licenses [8] Market Review and Outlook - The market showed strong performance with the Shanghai index recovering above 4100 points, while trading volume decreased by 633 billion compared to the previous day [9] - Sectors such as coal, transportation services, real estate, and construction materials saw significant gains, while technology sectors faced declines [9] - The report suggests maintaining a moderate position in investments, focusing on cyclical stocks as the market enters an earnings-driven phase [10]

Group 1 - The Ministry of Commerce will hold a press conference on February 5 to introduce key work in the business sector [2] - The global energy internet development cooperation organization will release the "Global Wind, Solar, and Hydropower Capacity Annual Forecast 2026" report on February 5 [2] - A total of 354 billion yuan in 7-day reverse repos will mature on February 5 [2] Group 2 - The 2026 Credit Market Work Conference emphasized support for expanding domestic demand, technological innovation, and small and medium-sized enterprises [4] - The State Administration for Market Regulation released 32 national metrology technical specifications, covering various fields including smart connected vehicles and health [4] - The Ministry of Culture and Tourism announced the resumption of travel for Shanghai residents to Kinmen and Matsu [4] Group 3 - Ibiden, a leading Japanese IC substrate manufacturer, announced a 500 billion yen (approximately 22.2 billion yuan) investment plan to expand high-performance IC substrate capacity from FY2026 to FY2028 [6] - The demand for IC substrates is increasing due to advancements in packaging technology, such as Chiplet packaging [6] - Chongda Technology announced a 1 billion yuan investment in a functional IC packaging substrate project in Jiangsu Province [6] Group 4 - The successful installation of the dome for the Zhangzhou Nuclear Power Unit 3 marks a significant milestone in the construction of the "Hualong One" nuclear power technology [8] - There are currently 41 units of "Hualong One" under construction or in operation, making it the most widely used nuclear power technology globally [9] - The World Nuclear Association projects that global nuclear power capacity could reach 1,446 GWe by 2050, surpassing the target set in the "Threefold Nuclear Energy Declaration" [9] Group 5 - The first brain-machine interface equipment for traditional Chinese medicine has been launched, aimed at patients with neurological injuries [10] - The technology is expected to revolutionize human-machine interaction, initially focusing on medical rehabilitation [10] - Companies like Weisi Medical and Innovation Medical are actively involved in the development of brain-machine interface technologies [10] Group 6 - Hengtong Optic-Electric has completed the construction of its AI advanced optical fiber materials R&D center and has entered the equipment installation phase [12] - Ruixin Technology is planning a major asset restructuring involving the acquisition of Wuhu Deheng Automotive Equipment Co., with stock suspension starting February 5 [12] - Changan Automobile plans to repurchase shares worth between 1 billion to 2 billion yuan to reduce registered capital [12] Group 7 - Shengxin Lithium Energy's subsidiary plans to acquire a 13.93% stake in Huirong Mining for 1.26 billion yuan, aiming for full control [13] - Sileck's subsidiary received a project confirmation letter from a South Korean battery client for cylindrical battery shell products, with an expected total procurement of approximately 360 million units [13] - Huibo Technology signed a contract worth 225 million USD (approximately 1.596 billion yuan) for the Naft Khana oilfield restoration project in Iraq [13] Group 8 - On February 3, stock-type ETFs (excluding cross-border ETFs) saw a net inflow of 6.965 billion yuan, marking a return to net inflows after a period of outflows [15] - The Southern CSI 500 ETF had a net inflow of 3.566 billion yuan, with several other ETFs also attracting significant investments [15] - The total scale of the Jiashi CSI 300 ETF has returned to over 100 billion yuan, reaching 100.824 billion yuan [15] Group 9 - JinkoSolar received a net buy of 104 million yuan from institutional seats, representing 2.52% of total trading volume [16] - The company signed a strategic cooperation agreement with Jintai Technology to jointly develop AI-based high-throughput perovskite tandem solar cells [16] - The expected mass production of perovskite tandem cells could significantly enhance efficiency and application in various scenarios [16] Group 10 - Honghe Technology received a net buy of 95.766 million yuan from institutional seats, accounting for 5.26% of total trading volume [17] - The company is a leading manufacturer of high-end electronic fabrics, benefiting from strong demand in AI-related applications [17] - Other companies such as Jingsheng Mechanical and China International Marine also saw net buys from institutional investors [17]

Core Viewpoint - The approval of the "Biopharmaceutical Industry Chain Open Innovation Development Plan" by the State Council provides opportunities for Jiangsu Province to strengthen and expand its leading position in the biopharmaceutical industry during the 14th Five-Year Plan period [1] Group 1: Policy Recommendations - Strengthen integrated policy supply and enhance service effectiveness by implementing an "Excellence Cultivation Plan" for innovative pharmaceutical companies and optimizing clinical trial subsidy application processes [1] - Promote an "early intervention, rolling submission" approval pathway for innovative drugs and medical devices, and establish a "one product, one special class" service mechanism [1] - Establish a "white list" system for the import and export of research and development materials in biopharmaceuticals and streamline the approval process for drug marketing licenses and production licenses [1] Group 2: Innovation Ecosystem - Build a comprehensive innovation ecosystem to enhance core industry momentum by attracting national clinical medical research centers and major infrastructure projects to Jiangsu [1] - Accelerate the establishment of provincial smart pharmacy laboratories and leverage national university technology transfer centers to support the establishment of new R&D institutions [1] - Implement a green channel for the listing and coding of innovative medical devices and promote data governance across departments in healthcare [1] Group 3: Talent and Financial Support - Strengthen support for essential resources by establishing a joint recruitment and cross-training mechanism for top talents between research institutions and enterprises [1] - Include AI pharmaceutical algorithm engineers in the provincial key talent cultivation directory and develop a supporting system for high-end talent [1] - Innovate financing products to support the development of customized financial products such as intellectual property pledge loans and establish an international drug registration service center [1]

Group 1 - The "Shengong-Hua Tuo" platform, the first brain-controlled acupuncture and neuro-rehabilitation equipment in China, has been launched, targeting patients with neurological disorders such as stroke-induced paralysis [1] - The platform is being tested in clinical trials at several top-tier hospitals, supported by the National Acupuncture Clinical Research Center [1] - According to Founder Securities, brain-machine interfaces are expected to become a core technology for human-machine interaction, initially focusing on medical rehabilitation and eventually enhancing brain-machine integration intelligence [1] Group 2 - Weisi Medical is focusing on non-invasive EEG collection and magnetic stimulation technology to build a closed-loop system for neuro-rehabilitation [1] - Innovative Medical is investing in both invasive and non-invasive brain-machine interface technologies through its stake in Boling Brain Machine, with its rehabilitation products already commercialized [2]

Core Viewpoint - The news highlights the recent surge in stock prices for Innovation Medical, Weisi Medical, and Jiachuan Video, driven by the announcement of China's first "Traditional Chinese Medicine Brain-Computer Interface" equipment being deployed, which has been tested in space on the Shenzhou series manned spacecraft [1] Group 1 - Innovation Medical's stock rose over 3% in the short term [1] - Weisi Medical and Jiachuan Video saw their stock prices increase by more than 1% [1] - The "Traditional Chinese Medicine Brain-Computer Interface" technology is now operational and has been utilized for space-based experiments [1]